Loading...
STENO logo

Stenocare A/SCPSE:STENO Stock Report

Market Cap DKK 63.9m
Share Price
DKK 1.48
My Fair Value
n/a
1Y0%
7D0.7%
Portfolio Value
View

Stenocare A/S

CPSE:STENO Stock Report

Market Cap: DKK 63.9m

Stenocare (STENO) Stock Overview

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. More details

STENO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

STENO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Stenocare A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for Stenocare
Historical stock prices
Current Share PriceDKK 1.48
52 Week HighDKK 2.80
52 Week LowDKK 0.19
Beta0.52
1 Month Change-10.03%
3 Month Change16.08%
1 Year Change0%
3 Year Change-84.96%
5 Year Change-93.18%
Change since IPO-96.07%

Recent News & Updates

Recent updates

Is Stenocare (CPH:STENO) In A Good Position To Deliver On Growth Plans?

Mar 29
Is Stenocare (CPH:STENO) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Stenocare's (CPH:STENO) Cash Burn Rate

Nov 29
We're Keeping An Eye On Stenocare's (CPH:STENO) Cash Burn Rate

Is Stenocare (CPH:STENO) In A Good Position To Deliver On Growth Plans?

Apr 02
Is Stenocare (CPH:STENO) In A Good Position To Deliver On Growth Plans?

Is Stenocare (CPH:STENO) In A Good Position To Invest In Growth?

Dec 18
Is Stenocare (CPH:STENO) In A Good Position To Invest In Growth?

Shareholder Returns

STENODK PharmaceuticalsDK Market
7D0.7%-1.8%-0.1%
1Y0%-47.3%-25.6%

Return vs Industry: STENO exceeded the Danish Pharmaceuticals industry which returned -46% over the past year.

Return vs Market: STENO exceeded the Danish Market which returned -24% over the past year.

Price Volatility

Is STENO's price volatile compared to industry and market?
STENO volatility
STENO Average Weekly Movement17.2%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement4.3%
10% most volatile stocks in DK Market10.3%
10% least volatile stocks in DK Market2.5%

Stable Share Price: STENO's share price has been volatile over the past 3 months compared to the Danish market.

Volatility Over Time: STENO's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Danish stocks.

About the Company

FoundedEmployeesCEOWebsite
20178Thomas Schnegelsbergstenocare.dk

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

Stenocare A/S Fundamentals Summary

How do Stenocare's earnings and revenue compare to its market cap?
STENO fundamental statistics
Market capDKK 63.93m
Earnings (TTM)-DKK 24.58m
Revenue (TTM)DKK 5.67m
11.3x
P/S Ratio
-2.6x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
STENO income statement (TTM)
RevenueDKK 5.67m
Cost of RevenueDKK 19.18m
Gross Profit-DKK 13.51m
Other ExpensesDKK 11.07m
Earnings-DKK 24.58m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.57
Gross Margin-238.06%
Net Profit Margin-433.19%
Debt/Equity Ratio109.9%

How did STENO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/01 09:46
End of Day Share Price 2025/12/30 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stenocare A/S is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.